- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
 |
24 days to go - register NOW!
Next Generation Molecular Diagnostics
12 - 13 June 2012, Movenpick Hotel, Prague, Czech Republic
|
Informa LifeSciences' Next Generation Molecular Diagnostics 2012 Conference
Discovery, development and validation strategies of cutting edge, high-value, molecular diagnostics to improve clinical decision-making, accelerate drug development and biomarker identification
The latest and most exciting developments in high value next generation molecular diagnostics, development of multi-marker diagnostics, next generation sequencing, gene panels, personalised medicine, companion diagnostics, and real time PCR developments and their translation into routine use across multiple disease states will be presented.
Why is Next Generation Molecular Diagnostics a MUST ATTEND for 2012?
- Critically review cutting edge developments and future visions for molecular diagnostics read more
- Explore the discovery, development and clinical validation strategies of emerging molecular diagnostics read more
- Identify innovations in the development of molecular diagnostics to aid personalised medicine
- Discover the benefit of the application of next generation sequencing for molecular diagnostics read more
- Uncover current advances in fully automated molecular diagnostics platforms read more
- Uncover new frontiers in cancer diagnostics
Next Generation Molecular Diagnostics 2012 Conference Speakers
- Trevor Hawkins, CEO, Next Generation Diagnostics, Siemens Healthcare Diagnostics, USA
- Guido Hennig, Senior Global Scientific Affairs Manager, Siemens Healthcare Diagnostics, Germany
- Malek Faham, Chief Scientific Officer, Sequenta Inc, USA
- Jonathan O’Halloran, Co-Founder & CSO, QuantuMDx, UK
- William Gallagher, Associate Professor of Cancer Biology, UCD Conway Institute, University College Dublin,
Chief Scientific Officer, OncoMark Limited, Ireland - Graham R Taylor, Head of Translational Genomics, Leeds Teaching Hospitals & Leeds University, UK
- Lilly Kong, Chief Scientific Officer, PrimeraDx, USA
- Tamara Maes, Chief Scientific Officer and Co-Founder, Oryzon Genomics, Spain
- Anders Lonneborg, Research Director, DiaGenic ASA, Norway
- Paul Coucke, Department of Medical Genetics, Ghent University Hospital, Belgium
- Sven Diederichs, Principal Investigator, German Cancer Research Center (DKFZ) & Dept. of Pathology, University Hospital Heidelberg, Germany
- Neil Avent, Head of School of Biomedical & Biological Sciences/ Associate Dean, School of Biomedical
and Biological Sciences (Faculty of Science and Technology), Plymouth University, UK - Peter Bogaert, Partner, Covington & Burling LLP (Brussels), Belgium
- Kewal Jain, CEO, Jain Pharma Biotech, Switzerland
..
Promotional Participant
..
..
..
Next Generation Molecular Diagnostics Workshops and Seminars
- Exploring Companion Diagnostics
Pre-Conference Workshop: Monday 11 June 2012
Workshop Leader: Sabah Malek, Senior Regulatory Scientist, Voisin Consulting, Inc. USA
- Integration of Next Generation Molecular Diagnositcs into Routine Use
Evening Seminar, Discussion and Dinner: Tuesday 12 June 2012
Seminar Leader: Kewal Jain, CEO, Jain Pharma Biotech, Switzerland
Next Generation Molecular Diagnostics is essential attendance for:
Directors, Vice Presidents, CSO, Heads, Scientists and Professors of:
- Molecular Diagnostics (MDx)
- R&D
- Clinical Diagnostics
- Companion Dx
- Personalised Medicine
- Biomarkers
- Next Generation Sequencing
- Pharmacogenomics
- Pharmacogenetics
- Genome /Genomics
- Genetics
- DNA Sequencing
- Oncology
Feeds | Like | Share    |
Dates and Venues
12 Jun 2012 - 13 Jun 2012
Movenpick Hotel, Prague, Czech Republic
Increased networking opportunities: Next Generation Molecular Diagnostics conference is co-located with
